Engineered Human Dental Pulp Stem Cells with Promising Potential for Regenerative Medicine.

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering
• Gene Engineering

Background:

• Stem cells are crucial for regenerative medicine due to their self-renewal and differentiation capabilities.
• Human dental pulp stem cells (DPSCs) are easily isolated, proliferate rapidly, and exhibit multilineage differentiation potential.
• Gene engineering allows modification of cell behavior and protein secretion for therapeutic purposes.

Purpose of the Study:

• To review current knowledge on gene-engineered DPSCs and their derivatives.
• To explore potential clinical applications of these modified cells.
• To focus specifically on applications in oral regeneration.

Main Methods:

• Review of existing literature on gene engineering techniques applied to DPSCs.
• Analysis of studies demonstrating DPSC differentiation and therapeutic potential.
• Investigation of Yamanaka factor-induced transdifferentiation into induced pluripotent stem cells (iPSCs).

Main Results:

• Gene-engineered DPSCs can be modified to express specific genes, alter behavior, or secrete therapeutic proteins.
• Transient expression of Yamanaka factors can induce transdifferentiation of DPSCs into iPSCs.
• Gene-engineered DPSCs show potential for tissue repair and regenerative medicine applications.

Conclusions:

• Gene-engineered DPSCs are promising candidates for regenerative medicine and tissue engineering.
• Clinical translation requires addressing challenges in safety, efficacy, and scalability.
• Oral regeneration is a key area of potential application for these advanced therapies.